Pacific Biosciences Of California Inc (PACB) - News Archive

The landscape of genomic research is evolving rapidly, particularly with regard to the need for precision and accuracy in identifying clinically relevant genetic variants. A recent multi-center study has demonstrated th...

In a transformative stride toward advancing genomic medicine, PacBio has partnered with Berry Genomics to secure the first regulatory approval for clinical long-read sequencing in China. The National Medical Products Ad...

In an era where the intricacies of genetics unravel myriad pathways leading to our understanding of health and disease, Pacific Biosciences of California Inc. (PacBio) has forged a strategic partnership with EpiCypher,...

In a significant stride towards democratizing genomic research, Pacific Biosciences (PacBio) has launched the Vega System, a new benchtop sequencing platform priced at $169,000. This development aims to make highly accu...

In a groundbreaking alliance poised to redefine the landscape of cancer genomics, PacBio has joined forces with Singapore’s National Precision Medicine (NPM) program. This strategic partnership aims to harness the full...

In a remarkable stride for the field of genomics, PacBio, A STAR, and Macrogen have collaborated to unveil a cutting-edge lab in Singapore, poised to revolutionize access to advanced genomic technologies in Southeast As...

Navigating New Frontiers: PacBio’s Inducement Grants and Their Implications for ShareholdersIn a pro-active endeavor to attract top-tier talent, Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leader in high-q...

In a groundbreaking announcement that promises to reshape the landscape of reproductive health, Pacific Biosciences of California Inc. (PacBio) unveiled the HiFi Solves Sub-fertility Consortium this month. This innovati...

In a groundbreaking venture, Revio is set to become a pivotal player in the realm of genetic research. The company s highly accurate long-read sequencing technology will spearhead initiatives at Münster University Hospi...

In an exciting development for genetic research and clinical diagnostics, Singapore s National Precision Medicine (NPM) programme announced a strategic partnership with Pacific Biosciences (PacBio), a global leader in h...

Advancing Precision Medicine in Southeast Asia: Singapore s National Precision Medicine Programme Teams Up with PacBioIn a significant development for the field of genomics and precision medicine, Singapore s National P...

Unleashing the Power of Long-Read Sequencing: Novogene Revolutionizes Research and Opens New Doors for Precision MedicineIn a groundbreaking move that promises to propel cancer, rare disease, and environmental research...

Pacific Biosciences of California Inc (PACB) is a leading biotechnology company that specializes in innovative genomic sequencing systems. Despite recent market challenges and fluctuations, PACB has managed to maintain...